Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01143441
What this trial is testing

Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
National Institute of Neurological Disorders and Stroke (NINDS) 48
Early research (Phase 1)Study completedNCT02515695
What this trial is testing

Phase I BP Interferon (IFN) Beta-001

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Centre Hospitalier Universitaire Vaudois 12
Not applicableStudy completedNCT00463710
What this trial is testing

Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 150
Testing effectiveness (Phase 2)Ended earlyNCT03239860
What this trial is testing

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GeNeuro SA 220
Not applicableLooking for participantsNCT05748015
What this trial is testing

Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Istituti Clinici Scientifici Maugeri SpA 60
Not applicableStudy completedNCT01538355
What this trial is testing

A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Charite University, Berlin, Germany 48
Not applicableStudy completedNCT06705608
What this trial is testing

Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study

Who this might be right for
Multiple SclerosisSkin CancerSkin Cancer Melanoma+3 more
University of British Columbia 4,000
Large-scale testing (Phase 3)WithdrawnNCT01941004
What this trial is testing

Safety and Efficacy of Fingolimod in MS Patients in China

Who this might be right for
Multiple Sclerosis (Relapsing Remitting)
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT04032158
What this trial is testing

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT00745615
What this trial is testing

An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Pharmaceutical Industries, Ltd. 257
Testing effectiveness (Phase 2)WithdrawnNCT00939549
What this trial is testing

High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Johns Hopkins University
Not applicableStudy completedNCT04567264
What this trial is testing

Wireless, Implantable Tibial Nerve Stimulator System for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Chiara Zecca 23
Large-scale testing (Phase 3)Study completedNCT04966338
What this trial is testing

Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple SclerosisRelapsing-Remitting
Cinnagen 170
Large-scale testing (Phase 3)Study completedNCT01067521
What this trial is testing

A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,404
Large-scale testing (Phase 3)Study completedNCT02545868
What this trial is testing

Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Hoffmann-La Roche 102
Post-approval studies (Phase 4)Study completedNCT01534182
What this trial is testing

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 298
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Not applicableUnknownNCT06611280
What this trial is testing

Deuterium Metabolic Imaging in People with Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
University of Aarhus 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07222956
What this trial is testing

Remibrutinib Using MR Imaging in Relapsing or Progressive MS

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Secondary ProgressiveMultiple Sclerosis (MS) Primary Progressive
Moein Amin 20
Not applicableUnknownNCT03004079
What this trial is testing

Clinical Importance of Glucose Regulation in Relapsing MS

Who this might be right for
Relapsing Remitting Multiple SclerosisClinically Isolated Syndrome
University of Virginia 160
Next Page